Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 22

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 22
---
 the thirtieth
day after the Release Date, we are contractually restricted from selling shares at a price that is less than $1.08 per the terms of the
Securities Purchase Agreement. This $1.08 price is well above the current price of our common stock; so we may not be able to sell shares
of common stock under the Sales Agreement in the near term unless and until the price of our common stock increases to $1.08 or above.
Further and until receipt of the Stockholder Approval, we only have seven authorized shares available for issuance pursuant to the Sales
Agreement. If we do not obtain the Stockholder Approval, of which there can be no assurance that we can or will obtain the Stockholder
Approval, or otherwise increase the available number of authorized shares of our common stock, we will be unable to materially utilize
the Sales Agreement. The number of shares that are sold through or to A.G.P. after our delivering a placement notice will also fluctuate
based on a number of factors, including the market price of our common stock during the sales period, the limits we set with A.G.P. in
any instruction to sell shares, and the demand for our common stock during the sales period. Because the price per share of each share
sold will fluctuate based on the market price of our common stock during this offering, it is not currently possible to predict the number
of shares, if any, that will be sold or the gross proceeds to be raised in connection with those sales.

The common stock offered hereby will be sold in “at the market offerings,” and investors who buy shares at different times will likely pay different prices.

Investors who purchase shares
in this offering at different times will likely pay different prices, and so may experience different levels of dilution and different
outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares
sold in this offering. Investors may experience a decline in the value of the shares they purchase in this offering as a result of sales
made at prices lower than the prices they paid.

We do not anticipate paying dividends on our capital stock.

We do not intend to pay cash
dividends on our capital stock in the foreseeable future. The declaration of dividends is subject to the discretion of our board of directors
and will depend on various factors, including our operating results, financial condition, future prospects and any other factors deemed
relevant by our board of